euro adhoc: LION Bioscience AG / Annual & Special Corporate Meetings / LION bioscience AG Receives Non-binding and Non-specific Take-over Respectively Purchase Offer (E)

---------------------------------------------------------------------
Disclosure announcement transmitted by euro adhoc.
The issuer is responsible for the content of this announcement.
---------------------------------------------------------------------

24.03.2005

In today’s extraordinary shareholder’s meeting the shareholder Ian
Humphrey-Smith informed the audience and LION bioscience AG about a
likely non-binding and non-specific take-over respectively purchase
offer for LION bioscience AG respectively for its assets. Mr.
Humphrey-Smith indicated that he would not act on his own behalf, but
on behalf of a group of investors namely FM Fund Management Ltd. and
Zapis Capital Group.

In case of a binding and specific take-over respectively purchase
offer, LION bioscience AG would review such an offer seriously.

Further inquiry note:
Günter Dielmann
Vice President Investor Relations
+49 (0) 6221-4038 249

end of announcement euro adhoc 24.03.2005 14:01:16
---------------------------------------------------------------------

emitter: LION Bioscience AG
Waldhofer Strasse 98
D-69123 Heidelberg
phone: +49 (0)6221 4038 0
FAX: +49 (0)6221 4038 101
mail: contact@lionbioscience.com
WWW: http://www.lionbioscience.com
ISIN: DE0005043509
indexes:
stockmarkets:
sector: Biotechnology
language: English

OTS-ORIGINALTEXT UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | OTB

print